PURE Stock Overview
Develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
PURE Bioscience, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.087 |
52 Week High | US$0.17 |
52 Week Low | US$0.059 |
Beta | 0.037 |
11 Month Change | -6.66% |
3 Month Change | 37.94% |
1 Year Change | -26.36% |
33 Year Change | -71.97% |
5 Year Change | -70.03% |
Change since IPO | -99.83% |
Recent News & Updates
Recent updates
Shareholder Returns
PURE | US Household Products | US Market | |
---|---|---|---|
7D | -19.6% | 1.4% | 0.5% |
1Y | -26.4% | 16.6% | 30.7% |
Return vs Industry: PURE underperformed the US Household Products industry which returned 17.9% over the past year.
Return vs Market: PURE underperformed the US Market which returned 32.3% over the past year.
Price Volatility
PURE volatility | |
---|---|
PURE Average Weekly Movement | 29.0% |
Household Products Industry Average Movement | 3.1% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.3% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PURE's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PURE's weekly volatility has increased from 24% to 29% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | 12 | Robert Bartlett | www.purebio.com |
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. Its technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products.
PURE Bioscience, Inc. Fundamentals Summary
PURE fundamental statistics | |
---|---|
Market cap | US$9.72m |
Earnings (TTM) | -US$3.35m |
Revenue (TTM) | US$1.96m |
5.0x
P/S Ratio-2.9x
P/E RatioIs PURE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PURE income statement (TTM) | |
---|---|
Revenue | US$1.96m |
Cost of Revenue | US$811.00k |
Gross Profit | US$1.15m |
Other Expenses | US$4.50m |
Earnings | -US$3.35m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.03 |
Gross Margin | 58.69% |
Net Profit Margin | -170.66% |
Debt/Equity Ratio | -103.0% |
How did PURE perform over the long term?
See historical performance and comparison